Allotment of 80,600 Equity shares having Face Value ?1/- each as per Company''s ESOP Plans
FUNDRAISE
● No Immediate Change
LOW RISK
📅 Filed on BSE: 01 Sep 2026, 03:13 PM IST · BSE ID: 8fa6d5c8-982f-4003-9f5c-105c9032e962
View Original BSE Filing (PDF)
💡
In Simple Terms
The company issued new shares to employees who exercised their stock options, slightly increasing its total shares.
🤖 AI Summary
- Sai Life Sciences allotted 80,600 equity shares under ESOP 2008 and MESOP 2018.
- The allotment increases issued and paid-up equity share capital to ₹21,23,94,216.
- Shares were issued on 01-09-2026 with a face value of ₹1/- each.
- The total exercise price for these shares was ₹22,68,000.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Number of shares issued
80,600
Face Value per share
₹1/-
Total Issued share capital before allotment
₹21,23,13,617/-
Total Issued share capital after allotment
₹21,23,94,216/-
Exercise price per share (ESOP 2008)
₹188.90/-
Exercise price per share (MESOP 2018)
₹23.30/-
Total Exercise Price (ESOP 2008)
₹27,57,740
Total Exercise Price (MESOP 2018)
₹15,37,800
Total Exercise Price (Allotment)
₹42,95,540
🏢 How This Affects the Company
This issuance is a routine part of employee compensation and does not alter the company's core business operations or market position.
The company's issued and paid-up equity share capital has increased by ₹80,600 to ₹21,23,94,216. The total exercise price received was ₹22,68,000.
No significant operational changes are indicated by this share allotment.
This is a standard ESOP exercise and does not introduce new risks.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this allotment.
👤
Who Is Affected
All existing shareholders are affected by a minor dilution of their proportionate ownership due to the issuance of 80,600 new equity shares.
🔍
Management Signal
The allotment signals management's continued commitment to its employee stock option plans as a retention and motivation tool.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Next quarterly results disclosure for updated capital structure.
Future announcements regarding new ESOP grants or exercises.
Any further regulatory filings related to share capital changes.
LOW RISK
Standard ESOP exercise, a routine event with minimal financial impact.
💡 Investor Takeaway
Sai Life Sciences Limited issued 80,600 equity shares via ESOP exercise, increasing capital to ₹21,23,94,216. Exercise prices varied by plan, with ₹188.90 for ESOP 2008 and ₹23.30 for MESOP 2018.
⚖️ Strengths & Concerns
✅ Positives
- Company continues to honor employee stock option plans, aligning employee interests with company growth.
⚠️ Concerns
- Dilution of existing shareholder equity due to the issuance of new shares.
❓ Frequently Asked Questions
How many shares did Sai Life Sciences allot under its ESOP plans?
Sai Life Sciences Limited allotted 80,600 equity shares under its ESOP 2008 and MESOP 2018 plans.
What is the face value of the shares allotted by Sai Life Sciences?
The face value of each equity share allotted by Sai Life Sciences is ₹1/-.
What was the total issued share capital of Sai Life Sciences after the allotment?
Following the allotment, the total issued and paid-up equity share capital of Sai Life Sciences increased to ₹21,23,94,216/-.
What were the exercise prices for the shares allotted under the ESOP plans?
The exercise price was ₹188.90/- per share for the 14,600 shares under ESOP 2008 and ₹23.30/- per share for the 66,000 shares under MESOP 2018.
Questions based on this BSE filing only. For information purposes.